超25亿支中医针具在广西启动集中采购

Core Insights - The first large-scale national alliance procurement for traditional Chinese medicine (TCM) acupuncture supplies took place on December 30, 2025, organized by the Guangxi Medical Insurance Bureau, covering 25 provinces and regions in China [1][2] - The procurement aims to reduce costs for patients while ensuring the quality and availability of medical supplies, focusing on commonly used items like acupuncture needles and cupping devices [1][2] Summary by Sections Procurement Details - The alliance procurement involves over 2.5 billion units of medical supplies, aiming to leverage bulk purchasing to lower prices and cover over 70% of the TCM service consumption market in China [1] - A group bidding mechanism was introduced, dividing companies into two groups: Group A for mainstream products with established clinical use and Group B for high-cost-performance new products, promoting innovation [1] Pricing and Competition - Multiple rules were implemented to ensure a balance where doctors are willing to use the products, patients can afford them, and companies can still profit [2] - The procurement cycle is set for two years, with the possibility of a one-year extension, and the selected results are expected to be implemented in the first half of 2026 [2] Future Implications - This procurement is seen as a significant step in building a China-ASEAN regional pharmaceutical trading platform, exploring new pathways for quality assurance, price reduction, and stable supply [2]